当前位置:首页 - 行情中心 - 君实生物-U(688180) - 财务分析 - 资产负债表

君实生物-U

(688180)

  

流通市值:252.99亿  总市值:326.16亿
流通股本:7.65亿   总股本:9.86亿

资产负债表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
流动资产:
货币资金2,521,771,403.862,502,201,285.662,474,595,086.042,711,730,023.03
应收票据及应收账款398,633,609.1509,816,712.45466,688,600.66449,904,393.75
应收账款398,633,609.1509,816,712.45466,688,600.66449,904,393.75
预付款项212,054,671.52199,787,005.7283,147,433.17267,236,638.39
其他应收款合计15,937,737.1436,441,479.37201,570,630.64201,787,961.6
存货589,122,166.6584,470,922.86567,442,634.42554,106,579.98
一年内到期的非流动资产2,261,036.152,187,306.154,746,758.429,336,705.99
其他流动资产14,597,152.6118,404,148.2917,334,532.5126,794,605.6
流动资产平衡项目0000
流动资产合计4,255,015,311.224,283,817,107.054,585,525,675.864,820,896,908.34
非流动资产:
长期股权投资266,335,176.68223,334,442.32228,455,933.85293,584,434.64
其他权益工具投资52,280,196.6562,565,091.1443,570,437.5456,134,213.7
其他非流动金融资产999,078,246.37940,504,669.94825,298,707.07799,204,148.37
固定资产2,222,958,081.722,281,061,188.572,315,877,222.082,363,540,377.29
在建工程1,885,992,451.781,858,563,731.171,693,261,195.291,525,473,513.14
使用权资产95,378,567.8455,598,802.5350,607,736.5430,215,309.8
无形资产514,192,112.93521,405,365.27526,498,411.05533,024,609.63
长期待摊费用7,786,740.456,120,035.128,015,516.2610,815,836.49
递延所得税资产94,045,901.387,045,275.35103,204,370.54102,228,141.29
其他非流动资产504,006,979.86461,944,701.64477,298,318.62453,895,968.92
非流动资产平衡项目0000
非流动资产合计6,642,054,455.586,498,143,303.056,272,087,848.846,168,116,553.27
资产平衡项目0000
资产总计10,897,069,766.810,781,960,410.110,857,613,524.710,989,013,461.61
流动负债:
短期借款943,930,283.74678,106,154.4631,656,782.41667,173,900.12
应付票据及应付账款1,058,927,840.61,232,683,826.19984,192,219.841,029,956,459.95
应付账款1,058,927,840.61,232,683,826.19984,192,219.841,029,956,459.95
合同负债118,269,684.338,165,732.53162,981,528.94154,278,073.67
应付职工薪酬261,049,686.61252,681,242.49232,595,559.68191,851,117.58
应交税费23,798,638.4639,575,276.6135,574,827.0836,307,882.2
其他应付款合计26,763,439.4335,768,048.6336,180,635.1143,640,269.58
一年内到期的非流动负债611,915,244.73246,789,095.44213,788,135.65154,434,228.4
其他流动负债3,236.16154,453.34617.738,563,217.12
流动负债平衡项目0000
流动负债合计3,044,658,054.062,493,923,829.632,296,970,306.442,286,205,148.62
非流动负债:
长期借款1,769,434,833.441,979,680,277.341,905,722,659.971,738,309,662.32
租赁负债68,297,319.3926,313,075.524,796,059.189,519,959.85
预计负债7,930,986.189,566,615.0117,624,701.4717,624,701.47
递延收益177,913,953.77181,913,109.58175,543,917.69177,199,159.48
其他非流动负债159,674,556.36158,433,738.89157,015,405.56155,597,072.22
非流动负债平衡项目0000
非流动负债合计2,183,251,649.142,355,906,816.322,280,702,743.872,098,250,555.34
负债平衡项目0000
负债合计5,227,909,703.24,849,830,645.954,577,673,050.314,384,455,703.96
所有者权益(或股东权益):
实收资本(或股本)985,689,871985,689,871985,689,871985,689,871
资本公积15,411,458,305.6715,406,557,142.1215,394,559,338.215,394,559,338.2
减:库存股30,892,473.0830,892,473.0830,892,473.0830,892,473.08
其他综合收益-170,141,648.92-159,937,004.34-190,011,657.5-166,409,457.44
未分配利润-10,575,869,426.04-10,340,993,199.41-9,986,835,322.23-9,705,021,448.29
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计5,620,244,628.635,860,424,336.296,172,509,756.396,477,925,830.39
少数股东权益48,915,434.9771,705,427.86107,430,718126,631,927.26
股东权益平衡项目0000
股东权益合计5,669,160,063.65,932,129,764.156,279,940,474.396,604,557,757.65
负债和股东权益合计10,897,069,766.810,781,960,410.110,857,613,524.710,989,013,461.61
公告日期2025-04-262025-03-282024-10-302024-08-31
审计意见(境内)标准无保留意见
TOP↑